Phase 2 Type 1 Diabetes Trial, Recruiting NCT06981234 Sponsor: University of California, San Diego Condition: Type 1 Diabetes
Back to Type 1 Diabetes

Phase 2 Type 1 Diabetes Trial, Recruiting

NCT06981234
Recruiting Phase 2

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years of age or older
  • If you cannot become pregnant, you must be at least 1 year past menopause or have had a surgical procedure that prevents pregnancy; if you can become pregnant, you must agree to use two forms of contraception for the entire study
  • If you are able to cause a pregnancy, you must be willing to use an acceptable form of contraception for the entire study
  • You have been diagnosed with Type 1 Diabetes and have been on a stable diabetes medication routine for at least 3 months
  • Your kidneys are functioning at an adequate level, as shown by a specific blood test called eGFR being 45 or above (confirm with trial site)
  • A blood test shows your bicarbonate level is at a normal or healthy level (confirm with trial site)
  • A urine drug screen comes back negative
  • You are able to read and sign a consent form that has been approved by an ethics review board

Who may not be able to join:

  • You have had an allergic reaction to acetazolamide or similar medications, or to any ingredients in the study tablets
  • You have liver disease, drink more than 14 alcoholic drinks per week, or have abnormal liver-related blood test results
  • Your HbA1c blood sugar level (a 3-month average of blood sugar control) is above 10.0%
  • Your hemoglobin (a measure of red blood cells) is below a certain level, indicating possible anemia (confirm with trial site)
  • You take more than 4 blood pressure medications, or your blood pressure reading was too high at your screening visit
  • You currently take certain types of water pills (diuretics), including loop, thiazide, or potassium-sparing diuretics
  • You have a serious active heart or lung condition, ongoing chest pain, unresolved blocked arteries, or severe heart failure that requires urgent medical attention
  • You live in a prison, nursing home, or have a significant mental illness that affects your ability to participate
  • You are currently pregnant, breastfeeding, or planning to become pregnant during the study
  • You are currently taking part in another clinical trial (observational studies are allowed)
  • In the opinion of the research team, you may have difficulty following the study's medical requirements
  • You are unable or unwilling to travel to the required study visits

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 5 July 2026
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Phone: 858-246-2146

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 2
Registry
ClinicalTrials.gov
Start date
14 August 2024
Est. completion
1 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in mGFR percent; Preservation of Serum Bicarbonate; Preservation of Serum Potassium; Change is albuminuria

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov